Transforming Oncology

Advancing GBM treatment through pioneering research and transformative therapies for improved patient outcomes.

Publications & Presentations

Our Focus

Our primary focus is on glioma, specifically glioblastoma multiforme (GBM), an aggressive and currently incurable form of brain cancer. With a deep understanding of the disease and a commitment to innovation, we aim to change the prognosis for patients suffering from this devastating condition. Discover more about glioblastoma multiforme and our approach to tackling it.

Learn More about Our Focus

For Patients

CNS Pharmaceuticals is dedicated to supporting patients and their families throughout their cancer journey. Our 'For Patients' page offers valuable resources, including information about our clinical trials, treatment options, and support networks. Visit our 'For Patients' page to learn more and find the help you need.

Learn More about For Patients

Our Pipeline

Our primary focus is on glioblastoma multiforme, an aggressive and currently incurable form of brain cancer. With a deep understanding of the disease and a commitment to innovation, we aim to change the prognosis for patients suffering from this devastating condition. Discover more about glioblastoma multiforme and our approach to tackling it.

Learn More about Our Pipeline

Latest News

CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

Read More of CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

CNS Pharmaceuticals Announces Reverse Stock Split

Read More of CNS Pharmaceuticals Announces Reverse Stock Split

CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase

Read More of CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
See All News Releases

Investor Relations

Explore our financial data and market performance. Get a clear picture of our strategic outlook.

Learn More about Investor Relations

Presentations

Access our comprehensive publications and presentations page for information on our research programs.

Learn More about Publications & Presentations

Email Alerts

Get timely updates on our latest developments. Subscribe to email alerts for new press releases, events, and filings.

Learn More about Investor Relations

Pipeline

Track our ongoing research and development projects. Monitor the progress and future of our drug programs.

Learn More about Pipeline